US FDA May Scrap Clinical Study Report Disclosure For New Drug Approvals

 
• By Derrick Gingery

The pilot project former Commissioner Gottlieb championed found only one sponsor interested in participating.

FDA entrance sign 2016
The FDA may shift its focus on improving approval transparency to the integrated review document template instead. • Source: File photo

More from Product Reviews

More from Pink Sheet